Bayer Report Opens Legal Options for Yaz Blood Clot Victims

Share Article

The Web’s largest source for information on Yaz legal news, side effects and research can be found at the Yaz Resource Center. Visit http://www.YazLawsuit.com

yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

The Yaz Resource Center, a patient advocacy group, is alerting women who allege a blood clot injury after taking Yaz or Yasmin that the maker of the drugs and court officials have reported settlement of injury claims. However, the time to file may be limited.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

On October 25, 2011, the British Medical Journal published a University of Copenhagen study which linked the hormone in Yaz to blood clots. The FDA followed on October 27, 2011 with its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the Institute for Safe Medicine Practices released its QuarterWatch report which ranked Yaz and Yasmin second highest in 2011 for the number of complications reported to the FDA.

Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The court estimates that more than 11,000 patients have filed a claim.

According to Bloomberg News on July 31st, Bayer has begun settling Yaz lawsuits, with as many as 1900 resolved so far. The company has reserved up to $610 million to dispense the cases at an average of around $212,000.

On July 11th, The Madison Record reported that Stephen Saltzburg, special master appointed to oversee settlement negotiations for the federal court, confirmed the settlements but estimated they could be concluded within a year.

The news of Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited. Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.

The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects of Yaz and litigation news related to the drug, or to speak with a lawyer, visit http://www.YazLawsuit.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website